In contrast, ALL numbers were significantly decreased in the BM and periphery of mice treated with CXCR4 antagonist (Figure 5H), which correlated with extended mouse survival (Figure 5I). This evidence concerns the gene CXCR4 and acute lymphoblastic leukemia.